Assenagon Asset Management S.A. Trims Stock Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Assenagon Asset Management S.A. lowered its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 3.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 104,410 shares of the company’s stock after selling 3,854 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.55% of USANA Health Sciences worth $2,816,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Millennium Management LLC purchased a new position in USANA Health Sciences in the 4th quarter worth approximately $633,000. Pzena Investment Management LLC grew its holdings in shares of USANA Health Sciences by 3.6% in the fourth quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock worth $39,015,000 after purchasing an additional 37,466 shares during the last quarter. Principal Financial Group Inc. raised its stake in shares of USANA Health Sciences by 2.8% during the fourth quarter. Principal Financial Group Inc. now owns 53,603 shares of the company’s stock valued at $1,924,000 after acquiring an additional 1,480 shares during the last quarter. Rhumbline Advisers lifted its holdings in USANA Health Sciences by 39.8% in the 4th quarter. Rhumbline Advisers now owns 49,390 shares of the company’s stock worth $1,773,000 after buying an additional 14,068 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in USANA Health Sciences by 7.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after acquiring an additional 55,059 shares in the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Stock Performance

USNA stock opened at $30.82 on Tuesday. The company has a market capitalization of $573.98 million, a PE ratio of 10.89, a price-to-earnings-growth ratio of 0.93 and a beta of 0.63. The company’s fifty day moving average price is $28.17 and its 200-day moving average price is $30.98. USANA Health Sciences, Inc. has a one year low of $23.10 and a one year high of $48.85.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.70 by $0.03. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. During the same quarter in the previous year, the company posted $0.86 EPS. On average, research analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on USNA shares. Wall Street Zen raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, May 22nd. Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. Finally, DA Davidson reduced their price target on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, February 27th.

Insider Activity at USANA Health Sciences

In related news, COO Walter Noot sold 6,291 shares of the business’s stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total transaction of $190,554.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO G Doug Iiekking sold 4,548 shares of the business’s stock in a transaction on Friday, May 9th. The shares were sold at an average price of $29.61, for a total transaction of $134,666.28. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 12,013 shares of company stock worth $360,149. Company insiders own 0.63% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.